HB 193 prohibits Utah government entities from using public funds to pay for certain surgical procedures related to transitioning from one's biological sex (defined as primary or secondary sex characteristic procedures). It requires government insurance plans that previously covered such transition procedures before May 6, 2026, to offer equivalent coverage for procedures to reverse those changes ("detransitioning"), to the extent possible. The bill takes effect on May 6, 2026, and does not appropriate new funds or affect private insurance. It directly impacts state and local government agencies, school districts, and other public entities using public money for health coverage.
HB 295, the "Overdose Amendments," updates Utah's criminal code to better address overdose situations. It expands the affirmative defense for reporting overdoses to include both the person experiencing the overdose and anyone who stays with them during the event. The bill also creates a new option for courts to dismiss first-time drug offenses if the individual commits to substance abuse treatment, and clarifies that reporting an overdose can be used as a sentencing mitigating factor for both parties involved. These changes aim to reduce criminal penalties for overdose-related incidents while encouraging treatment engagement.
HB 442 requires manufacturers of menstrual products sold in Utah to list specific chemicals (like lead, cadmium, arsenic, and PFAS) and intentionally added ingredients on product packaging. It directly affects manufacturers of tampons, sanitary napkins, menstrual cups, and similar products sold in the state. The Division of Consumer Protection will enforce these labeling rules and create related regulations. This bill increases transparency about ingredients in feminine hygiene products without changing product safety standards or requiring new funding.
HB 14 extends the expiration date for Utah's Behavior Analyst Licensing Act from July 1, 2026, to July 1, 2036. This change ensures the law governing behavior analyst licensure remains in effect for an additional decade, preventing its automatic repeal. The bill includes minor technical adjustments to the relevant code but does not alter licensing requirements for behavior analysts. This extension directly affects behavior analysts and the state's regulatory process for their professional licensing.
HB 28 extends the expiration dates for several health-related programs and committees under Utah's Department of Health and Human Services. It specifically delays the sunset (repeal) of programs like the Rare Disease Advisory Council Grant Program, Newborn Hearing Screening Committee, Mobile Crisis Outreach Team Grant Program, and Behavioral Health Receiving Center Grant Program, pushing their expiration dates from 2026 to 2036 or later. The bill amends Utah Code sections to adjust these repeal deadlines without creating new programs or appropriating funds. These changes directly affect the ongoing operation of these advisory bodies and grant initiatives, allowing them to continue functioning past their original expiration dates.
HB 70 requires Utah's Department of Health and Human Services to implement a new electronic health record system for inmate care by 2026, based on a working group's recommendations. It makes funds for unexpected high-cost correctional health care non-lapsing (meaning they won't expire if unused), and mandates a treatment plan for all inmates with substance use disorders, including medication-based treatment. The bill also sets accreditation standards for correctional health facilities and allows parole boards to consider health examiner reports when deciding parole conditions. These changes directly affect inmates in Utah's correctional facilities, the Department of Health and Human Services, and the Department of Corrections.
HB 356 clarifies Utah's rules for the federal 340B drug discount program, which provides discounted medications to eligible healthcare organizations. It defines key terms like "340B covered entity" (e.g., hospitals or clinics participating in the federal program) and prohibits drug manufacturers from restricting contracts between pharmacies and these entities or requiring excessive data sharing beyond federal requirements. The bill directly affects 340B-covered entities, pharmacies, and drug manufacturers by ensuring they cannot interfere with program participation or impose unnecessary conditions. It makes technical updates to Utah law without new funding, aligning state rules with federal program standards.
HB 7 is the Social Services Base Budget for Utah’s fiscal years 2026 and 2027, providing $8.6 billion in total funding to state agencies, primarily the Department of Health and Human Services. It directly affects programs like Child and Family Services, Medicaid, mental health services, and health care administration by allocating specific funds - such as $1.588 billion from the General Fund for 2027 and $53.38 million for legal cost reporting. Key provisions include requiring the Health and Human Services Department to report to lawmakers by May 2026 on attorney fees for child welfare services, including historical costs and funding gaps. The bill establishes concrete budget allocations for operations, capital projects, and specific initiatives without changing program eligibility or creating new requirements.